Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $5 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $0 | $0 |
| Total Curr. Assets | $2 | $2 | $6 | $7 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $352 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $3 | $1 | -$352 |
| Total NC Assets | $1 | $4 | $2 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3 | $6 | $8 | $8 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $1 | $0 |
| Short-Term Debt | $2 | $81 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $1 | $1 | $0 |
| Total Curr. Liab. | $9 | $85 | $2 | $1 |
| LT Debt | $1 | $14 | $40 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $14 | $40 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $0 |
| Total Liabilities | $10 | $100 | $42 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $9 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$113 | -$100 | -$39 | -$17 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $98 | $5 | $5 | $1 |
| Total Equity | -$7 | -$94 | -$34 | -$16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3 | $6 | $8 | $8 |
| Net Debt | $2 | $94 | $35 | $16 |